Latest Articles

Publication Date
Son of Endometriosis Patient Running NYC Marathon to Honor His Mom and Bring Awareness to the Disease - Endometriosis Foundation of America - The Blossom

Son of Endometriosis Patient Running NYC Marathon to Honor His Mom and Bring Awareness to the Disease Endometriosis Foundation of America - The Blossom

Published: Oct. 24, 2024, 7:10 p.m.
Racial disparities in high-risk endometrial subtype diagnoses reported - Contemporary Obgyn

Racial disparities in high-risk endometrial subtype diagnoses reported Contemporary Obgyn

Published: Oct. 24, 2024, 6:26 p.m.
Neoadjuvant Treatment Considerations for Endometrial Cancer - Cancer Network

Neoadjuvant Treatment Considerations for Endometrial Cancer Cancer Network

Published: Oct. 24, 2024, 6:19 p.m.
Molecular Classification of Endometrial Cancer - Cancer Network

Molecular Classification of Endometrial Cancer Cancer Network

Published: Oct. 24, 2024, 6:19 p.m.
Overview of Endometrial Cancer - Cancer Network

Overview of Endometrial Cancer Cancer Network

Published: Oct. 24, 2024, 6:14 p.m.
Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer - OncLive

Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer OncLive

Published: Oct. 24, 2024, 3:55 p.m.
Pharmacokinetic Relationship Between GLP-1s, Endometrial Cancer Cell Growth - DocWire News

Pharmacokinetic Relationship Between GLP-1s, Endometrial Cancer Cell Growth DocWire News

Published: Oct. 24, 2024, 2:55 p.m.
Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer - Medscape

Episode 6: The Evolving Role of Radiation Therapy in Endometrial Cancer Medscape

Published: Oct. 24, 2024, 1:44 p.m.
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation BioSpace

Published: Oct. 24, 2024, 5:36 a.m.
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - PR Newswire

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation PR Newswire

Published: Oct. 24, 2024, 12:08 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!